(UPDATED) There is no difference in in-hospital outcomes or longer-term mortality between patients undergoing revascularization with either a durable-polymer DES or newer technology with a ...

LONDON--(BUSINESS WIRE)--The biliary stents market is poised to grow by USD 27.81 million during 2020-2024, progressing at a CAGR of about 4% during the forecast period. Worried about the impact of ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio CHICAGO — A novel bioabsorbable ...

SAN FRANCISO, CA—In 6-month results, a new paclitaxel-eluting bioabsorbable stent shows a strong safety profile and improved efficacy compared with an absorbable bare-metal predecessor, according to a ...

Washington, DC - Predicting the future is a fool's game, and predicting successful drug and device therapy in cardiovascular medicine is just as tricky. When bioabsorbable stents emerged on the radar ...

A study published today online in The Lancet (March 13, 2009) presented two year data for the bioabsorbable everolimus coronary stent. Commenting on the results, interventional cardiology specialist, ...

For about a decade, bioabsorbable stents were hailed as one of the most promising technologies in cardiology. Now, the future prospects of the technology are less than certain after a clinical trial ...

The use of slow-release drugs in stents (drug-eluting stents) has dramatically reduced restenosis rates after percutaneous coronary intervention. However, these permanent metal devices may impair ...

Bioabsorbable cardiac devices such as Abbott's Absorb bioresorbable vascular scaffold, currently in development, could prove to be quite profitable. "The survey provided dramatic differences between ...

A new study presented two-year data for the bioabsorbable everolimus coronary stent. An interventional cardiology specialist and official spokesperson for the European Society of Cardiology has ...